학술논문
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Document Type
Article
Author
Woo, Jong Shin; Hong, Soon Jun; Cha, Dong Hoon; Kim, Kee Sik; Kim, Moo Hyun; Lee, Jun-Won; Jeong, Myung Ho; Jeong, Jin-Ok; Lee, Jun-Hee; Jeon, Doo Soo; Cho, Eun Joo; Kim, Soon Kil; Kwan, Jun; Park, Chang Gyu; Lee, Hae Young; Hong, Taek Jong; Shin, Jinho; Youn, Ho Joong; Jeon, Dong Woon; Chung, Wook Jin; Jeong, Ju Cheol; Kim, Chong Jin
Source
In Clinical Therapeutics August 2021 43(8):1419-1430
Subject
Language
ISSN
0149-2918